Animal models of medullary thyroid cancer

state of the art and view to the future

Giovanni Vitale, Germano Gaudenzi, Luisa Circelli, Marco F Manzoni, Andrea Bassi, Niccolò Fioritti, Antongiulio Faggiano, Annamaria Colao, NIKE Group

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Medullary thyroid carcinoma is a neuroendocrine tumour originating from parafollicular C cells accounting for 5-10% of thyroid cancers. Increased understanding of disease-specific molecular targets of therapy has led to the regulatory approval of two drugs (vandetanib and cabozantinib) for the treatment of medullary thyroid carcinoma. These drugs increase progression-free survival; however, they are often poorly tolerated and most treatment responses are transient. Animal models are indispensable tools for investigating the pathogenesis, mechanisms for tumour invasion and metastasis and new therapeutic approaches for cancer. Unfortunately, only few models are available for medullary thyroid carcinoma. This review provides an overview of the state of the art of animal models in medullary thyroid carcinoma and highlights future developments in this field, with the aim of addressing salient features and clinical relevance.

Original languageEnglish
Pages (from-to)R1-R12
JournalEndocrine-Related Cancer
Volume24
Issue number1
DOIs
Publication statusPublished - Jan 2017

Fingerprint

Animal Models
Drug Approval
Neuroendocrine Tumors
Thyroid Neoplasms
Disease-Free Survival
Neoplasms
Neoplasm Metastasis
Medullary Thyroid cancer
Therapeutics
Pharmaceutical Preparations

Keywords

  • Review
  • Journal Article

Cite this

Animal models of medullary thyroid cancer : state of the art and view to the future. / Vitale, Giovanni; Gaudenzi, Germano; Circelli, Luisa; Manzoni, Marco F; Bassi, Andrea; Fioritti, Niccolò; Faggiano, Antongiulio; Colao, Annamaria; NIKE Group.

In: Endocrine-Related Cancer, Vol. 24, No. 1, 01.2017, p. R1-R12.

Research output: Contribution to journalReview article

Vitale, G, Gaudenzi, G, Circelli, L, Manzoni, MF, Bassi, A, Fioritti, N, Faggiano, A, Colao, A & NIKE Group 2017, 'Animal models of medullary thyroid cancer: state of the art and view to the future', Endocrine-Related Cancer, vol. 24, no. 1, pp. R1-R12. https://doi.org/10.1530/ERC-16-0399
Vitale, Giovanni ; Gaudenzi, Germano ; Circelli, Luisa ; Manzoni, Marco F ; Bassi, Andrea ; Fioritti, Niccolò ; Faggiano, Antongiulio ; Colao, Annamaria ; NIKE Group. / Animal models of medullary thyroid cancer : state of the art and view to the future. In: Endocrine-Related Cancer. 2017 ; Vol. 24, No. 1. pp. R1-R12.
@article{b3b2aef4f20b4564b7aa610365ae7c50,
title = "Animal models of medullary thyroid cancer: state of the art and view to the future",
abstract = "Medullary thyroid carcinoma is a neuroendocrine tumour originating from parafollicular C cells accounting for 5-10{\%} of thyroid cancers. Increased understanding of disease-specific molecular targets of therapy has led to the regulatory approval of two drugs (vandetanib and cabozantinib) for the treatment of medullary thyroid carcinoma. These drugs increase progression-free survival; however, they are often poorly tolerated and most treatment responses are transient. Animal models are indispensable tools for investigating the pathogenesis, mechanisms for tumour invasion and metastasis and new therapeutic approaches for cancer. Unfortunately, only few models are available for medullary thyroid carcinoma. This review provides an overview of the state of the art of animal models in medullary thyroid carcinoma and highlights future developments in this field, with the aim of addressing salient features and clinical relevance.",
keywords = "Review, Journal Article",
author = "Giovanni Vitale and Germano Gaudenzi and Luisa Circelli and Manzoni, {Marco F} and Andrea Bassi and Niccol{\`o} Fioritti and Antongiulio Faggiano and Annamaria Colao and {NIKE Group}",
note = "{\circledC} 2017 Society for Endocrinology.",
year = "2017",
month = "1",
doi = "10.1530/ERC-16-0399",
language = "English",
volume = "24",
pages = "R1--R12",
journal = "Endocrine-Related Cancer",
issn = "1351-0088",
publisher = "BioScientifica Ltd.",
number = "1",

}

TY - JOUR

T1 - Animal models of medullary thyroid cancer

T2 - state of the art and view to the future

AU - Vitale, Giovanni

AU - Gaudenzi, Germano

AU - Circelli, Luisa

AU - Manzoni, Marco F

AU - Bassi, Andrea

AU - Fioritti, Niccolò

AU - Faggiano, Antongiulio

AU - Colao, Annamaria

AU - NIKE Group

N1 - © 2017 Society for Endocrinology.

PY - 2017/1

Y1 - 2017/1

N2 - Medullary thyroid carcinoma is a neuroendocrine tumour originating from parafollicular C cells accounting for 5-10% of thyroid cancers. Increased understanding of disease-specific molecular targets of therapy has led to the regulatory approval of two drugs (vandetanib and cabozantinib) for the treatment of medullary thyroid carcinoma. These drugs increase progression-free survival; however, they are often poorly tolerated and most treatment responses are transient. Animal models are indispensable tools for investigating the pathogenesis, mechanisms for tumour invasion and metastasis and new therapeutic approaches for cancer. Unfortunately, only few models are available for medullary thyroid carcinoma. This review provides an overview of the state of the art of animal models in medullary thyroid carcinoma and highlights future developments in this field, with the aim of addressing salient features and clinical relevance.

AB - Medullary thyroid carcinoma is a neuroendocrine tumour originating from parafollicular C cells accounting for 5-10% of thyroid cancers. Increased understanding of disease-specific molecular targets of therapy has led to the regulatory approval of two drugs (vandetanib and cabozantinib) for the treatment of medullary thyroid carcinoma. These drugs increase progression-free survival; however, they are often poorly tolerated and most treatment responses are transient. Animal models are indispensable tools for investigating the pathogenesis, mechanisms for tumour invasion and metastasis and new therapeutic approaches for cancer. Unfortunately, only few models are available for medullary thyroid carcinoma. This review provides an overview of the state of the art of animal models in medullary thyroid carcinoma and highlights future developments in this field, with the aim of addressing salient features and clinical relevance.

KW - Review

KW - Journal Article

U2 - 10.1530/ERC-16-0399

DO - 10.1530/ERC-16-0399

M3 - Review article

VL - 24

SP - R1-R12

JO - Endocrine-Related Cancer

JF - Endocrine-Related Cancer

SN - 1351-0088

IS - 1

ER -